Company Description
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States.
It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services.
In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines.
Further, the company offers in home sleep apnea testing services.
Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Country | United States |
IPO Date | Aug 9, 2019 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 1,142 |
CEO | Casey Hoyt |
Contact Details
Address: 625 East Kaliste Saloom Road Lafayette, Louisiana United States | |
Website | https://www.viemed.com |
Stock Details
Ticker Symbol | VMD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001729149 |
CUSIP Number | 92663R105 |
ISIN Number | CA92663R1055 |
Employer ID | 00-0000000 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Casey Hoyt | Chief Executive Officer & Director |
Jeremy Trahan | EVice President, Chief Legal Officer & Corporate Secretary |
Trae Paul Fitzgerald | Chief Financial Officer |
William Todd Zehnder | Chief Operating Officer & Director |
Dr. William Dana Frazier M.D. | Chief Medical Officer & Director |
Jerome Richard Cambre II | Vice President of Sales |
Michael Freeman | Chief Business Development Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 26, 2024 | 4 | Filing |
Nov 21, 2024 | 4 | Filing |
Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
Nov 13, 2024 | 4 | Filing |
Nov 13, 2024 | 4 | Filing |
Nov 13, 2024 | SCHEDULE 13G/A | [Amend] Filing |
Nov 12, 2024 | 8-K | Current Report |
Nov 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 06, 2024 | 10-Q | Quarterly Report |
Nov 06, 2024 | 8-K | Current Report |